AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+0.39%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$2.64B
AUM Growth
+$2.64B
(-30%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-44.32%
Top 10 Holdings %
Top 10 Hldgs %
37.78%
Holding
281
New
59
Increased
39
Reduced
77
Closed
79
Top Buys
| 1 |
GE HealthCare
GEHC
|
$33.6M |
| 2 |
McDonald's
MCD
|
$30.3M |
| 3 |
ImmunityBio
IBRX
|
$20.5M |
| 4 |
GitLab
GTLB
|
$14.6M |
| 5 |
MongoDB
MDB
|
$12.3M |
Top Sells
| 1 |
Exact Sciences
EXAS
|
$54.8M |
| 2 |
Spectrum Brands
SPB
|
$49.4M |
| 3 |
Simply Good Foods
SMPL
|
$46.6M |
| 4 |
Sensient Technologies
SXT
|
$43.9M |
| 5 |
FibroGen
FGEN
|
$43.3M |
Sector Composition
| 1 | Healthcare | 69.03% |
| 2 | Consumer Discretionary | 12.86% |
| 3 | Technology | 10.97% |
| 4 | Consumer Staples | 3.25% |
| 5 | Communication Services | 2.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
PTC Therapeutics
PTCT
$3.92B
| $231M | 3.99% | 4,735,464 -699,379 | -13% | -$34.2M |
|
2
Supernus Pharmaceuticals
SUPN
$2.53B
| $152M | 2.62% | 4,812,000 -384,000 | -7% | -$12.1M |
|
3
Travere Therapeutics
TVTX
$1.56B
| $131M | 2.27% | 8,876,000 +4,000 | +0% | +$59.2K |
|
4
Incyte
INCY
$16.5B
| $91M | 1.57% | 1,336,000 -335,463 | -20% | -$22.8M |
|
5
Neurocrine Biosciences
NBIX
$13.8B
| $85M | 1.47% | 676,024 -324,166 | -32% | -$40.7M |
|
6
Immunovant
IMVT
$2.56B
| $83.2M | 1.44% | 5,200,000 +700,000 | +16% | +$11.2M |
|
7
Grifois
GRFS
$6.78B
| $66M | 1.14% | 7,298,000 -1,980,000 | -21% | -$17.9M |
|
|
8
GE HealthCare
GEHC
$33.7B
| $56M | 0.97% | 756,281 +453,221 | +150% | +$33.6M |
|
9
Regeneron Pharmaceuticals
REGN
$61.5B
| $52.5M | 0.91% | 100,032 -14,041 | -12% | -$7.37M |
|
10
FIVE9
FIVN
$2.08B
| $48.6M | 0.84% | 1,836,000 -262,000 | -12% | -$6.94M |
|
11
Amazon
AMZN
$2.44T
| $48.1M | 0.83% | 219,423 -44,703 | -17% | -$9.81M |
|
12
STAAR Surgical
STAA
$1.36B
| $47.2M | 0.81% | 2,812,000 -188,000 | -6% | -$3.15M |
|
13
argenx
ARGX
$43.6B
| $44.1M | 0.76% | 80,000 -18,000 | -18% | -$9.92M |
|
14
Cytokinetics
CYTK
$4.23B
| $43.4M | 0.75% | 1,312,349 +288,959 | +28% | +$9.55M |
|
|
15
McDonald's
MCD
$224B
| $41.9M | 0.72% | 143,580 +103,580 | +259% | +$30.3M |
|
16
Microsoft
MSFT
$3.77T
| $41.7M | 0.72% | 83,737 -48,263 | -37% | -$24M |
|
|
17
Exact Sciences
EXAS
$8.98B
| $39.4M | 0.68% | 741,956 -1,030,413 | -58% | -$54.8M |
|
18
Agios Pharmaceuticals
AGIO
$2.19B
| $38.8M | 0.67% | 1,168,000 -880,000 | -43% | -$29.3M |
|
19
Freshpet
FRPT
$2.72B
| $38.4M | 0.66% | 565,403 -151,557 | -21% | -$10.3M |
|
20
Madrigal Pharmaceuticals
MDGL
$9.76B
| $37.5M | 0.65% | 124,000 -11,883 | -9% | -$3.6M |
|
21
Treace Medical Concepts
TMCI
$464M
| $36.8M | 0.64% | 6,260,000 +49,000 | +0.8% | +$288K |
|
22
Kura Oncology
KURA
$686M
| $35.8M | 0.62% | 6,200,000 -372,000 | -6% | -$2.15M |
|
23
Alphabet (Google) Class A
GOOGL
$2.57T
| $33.6M | 0.58% | 190,400 -106,600 | -36% | -$18.8M |
|
24
Orthofix Medical
OFIX
$592M
| $33.2M | 0.57% | 2,978,000 +14,000 | +0.5% | +$156K |
|
25
Biohaven
BHVN
$1.63B
| $30.1M | 0.52% | 2,136,000 +462,578 | +28% | +$6.53M |
|